Company
JumpCode Genomics
The majority of molecules sequenced are uninformative. Jumpcode Genomics is changing that by helping researchers boost usable NGS data.
Also known as Jumpcode Genomics, Inc
- Business model
- B2B
- Legal name
- Jumpcode Genomics, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
JumpCode Genomics is a U.S.-based manufacturer of genetic testing reagents that provide the patented CRISPRClean technology
Funding snapshot
- Total raised
- $38.7MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $3.5M2024-08-15
Funding rounds
- Round, 2024
- $3.5M2024-08-15, SEC form D sold, 8 investors
- Round, 2023
- $9.2M2023-04-27, SEC form D sold, 7 investors
- Round, 2020
- $21M2020-12-18, SEC form D sold, 5 investors
- Round, 2020
- $1.5M2020-01-27, SEC form D sold, 1 investor
- Round, 2018
- $3.5M2018-09-04, SEC form D sold, 4 investors
Loading relationship preview